welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Business

Business & Economics

Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts?

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

83% Informative

Janux Therapeutics Inc. (NASDAQ:JANX) is a clinical-stage biopharmaceutical company that develops immunotherapies for cancer.

The company is concentrating its efforts on its TRACTr therapy, specifically JANX007, which targets prostate-specific membrane antigen antigen PSMA.

Janux Therapeutics Inc. (NASDAQ:JANX) has not yet met all the benchmarks necessary to establish a competitive advantage and attract a pharmaceutical acquisition.

Overall, JANX ranks 1st on our list of the best up and coming stocks to buy according to Wall Street Analysts.